Announced Sat, 8 Aug · 12:43 IST
Newspaper publication of quarter ended June 30 2026 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹17.99
prior close
₹18.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+2.5+2.5+2.7-0.1-6.6-2.7-6.6-2.7-2.8-12.0-18.8——
Up moveDown movePending
AI summary
Venmax Drugs and Pharmaceuticals has submitted copies of newspaper advertisements of its unaudited financial results for the quarter ended June 30, 2026. The results were published in Financial Express and Nava Telangana on August 8, 2026, as required under SEBI listing regulations. The filing is a routine compliance disclosure and the results are also available on the company's website.
Likely market impact
Routine compliance filing. No new financial details. Quarterly results already disclosed earlier; no expected price impact.